Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug

investors.com/news/technology/neurocrine-biosciences-stock-neurocrine-biosciences-earnings-q1-2025

Neurocrine Biosciences shares catapulted Tuesday on "surprising commercial momentum" for its newest drug, Crenessity.
The post Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-05-06 15:24:29.
The Entire Business World on a Single Page. Free to Use →